- Home
- LRE vs PMVP Comparison
LRE vs PMVP Comparison
Compare LRE & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRE
- PMVP
- Stock Information
- Founded
- LRE 2001
- PMVP 2013
- Country
- LRE Japan
- PMVP United States
- Employees
- LRE N/A
- PMVP N/A
- Industry
- LRE
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- LRE
- PMVP Health Care
- Exchange
- LRE Nasdaq
- PMVP Nasdaq
- Market Cap
- LRE 24.4M
- PMVP 62.3M
- IPO Year
- LRE 2023
- PMVP 2020
- Fundamental
- Price
- LRE $1.78
- PMVP $1.35
- Analyst Decision
- LRE
- PMVP Strong Buy
- Analyst Count
- LRE 0
- PMVP 1
- Target Price
- LRE N/A
- PMVP $5.00
- AVG Volume (30 Days)
- LRE 8.9K
- PMVP 245.8K
- Earning Date
- LRE 01-01-0001
- PMVP 08-07-2025
- Dividend Yield
- LRE N/A
- PMVP N/A
- EPS Growth
- LRE N/A
- PMVP N/A
- EPS
- LRE N/A
- PMVP N/A
- Revenue
- LRE $110,330,328.00
- PMVP N/A
- Revenue This Year
- LRE N/A
- PMVP N/A
- Revenue Next Year
- LRE N/A
- PMVP N/A
- P/E Ratio
- LRE N/A
- PMVP N/A
- Revenue Growth
- LRE 3.92
- PMVP N/A
- 52 Week Low
- LRE $1.10
- PMVP $0.81
- 52 Week High
- LRE $2.49
- PMVP $1.82
- Technical
- Relative Strength Index (RSI)
- LRE 55.78
- PMVP 63.34
- Support Level
- LRE $1.72
- PMVP $1.29
- Resistance Level
- LRE $1.84
- PMVP $1.39
- Average True Range (ATR)
- LRE 0.04
- PMVP 0.08
- MACD
- LRE -0.01
- PMVP 0.01
- Stochastic Oscillator
- LRE 53.52
- PMVP 78.87
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.